Pfizer Inc (PFE)
27.74
-0.04
(-0.14%)
USD |
NYSE |
Mar 28, 16:00
27.76
+0.02
(+0.07%)
After-Hours: 16:19
Pfizer Price: 27.74 for March 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 27.71 | 27.94 | 27.54 | 27.78 | 33.55M |
Mar 26, 2024 | 27.45 | 27.63 | 27.31 | 27.59 | 38.22M |
Mar 25, 2024 | 27.24 | 27.48 | 27.10 | 27.43 | 31.11M |
Mar 22, 2024 | 27.47 | 27.84 | 27.34 | 27.36 | 28.83M |
Mar 21, 2024 | 27.75 | 28.04 | 27.63 | 27.66 | 29.63M |
Mar 20, 2024 | 27.48 | 27.74 | 27.21 | 27.70 | 34.47M |
Mar 19, 2024 | 27.67 | 27.78 | 27.32 | 27.63 | 29.03M |
Mar 18, 2024 | 28.01 | 28.02 | 27.61 | 27.72 | 36.23M |
Mar 15, 2024 | 27.96 | 28.28 | 27.86 | 27.94 | 75.73M |
Mar 14, 2024 | 28.25 | 28.28 | 27.77 | 28.13 | 36.43M |
Mar 13, 2024 | 28.29 | 28.69 | 28.19 | 28.22 | 39.27M |
Mar 12, 2024 | 28.31 | 28.34 | 27.76 | 28.01 | 48.76M |
Mar 11, 2024 | 27.31 | 28.39 | 27.31 | 28.37 | 52.60M |
Mar 08, 2024 | 26.88 | 27.30 | 26.85 | 27.22 | 45.91M |
Mar 07, 2024 | 27.20 | 27.32 | 26.76 | 26.79 | 46.42M |
Mar 06, 2024 | 26.90 | 27.30 | 26.78 | 27.19 | 84.92M |
Mar 05, 2024 | 25.87 | 26.42 | 25.69 | 26.08 | 73.65M |
Mar 04, 2024 | 26.30 | 26.46 | 25.61 | 25.89 | 86.78M |
Mar 01, 2024 | 26.82 | 26.90 | 26.51 | 26.59 | 46.39M |
Feb 29, 2024 | 27.07 | 27.19 | 26.55 | 26.56 | 54.64M |
Feb 28, 2024 | 26.96 | 27.24 | 26.82 | 27.04 | 31.01M |
Feb 27, 2024 | 27.12 | 27.20 | 26.81 | 26.89 | 38.60M |
Feb 26, 2024 | 27.67 | 27.67 | 27.07 | 27.18 | 45.69M |
Feb 23, 2024 | 27.75 | 28.09 | 27.69 | 27.76 | 33.18M |
Feb 22, 2024 | 27.59 | 27.70 | 27.18 | 27.55 | 31.96M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
25.89
Minimum
Mar 04 2024
61.25
Maximum
Dec 16 2021
39.73
Average
38.30
Median
May 10 2023
Price Benchmarks
Amgen Inc | 284.27 |
Gilead Sciences Inc | 73.24 |
Johnson & Johnson | 158.15 |
Viking Therapeutics Inc | 81.96 |
Moderna Inc | 106.58 |
Price Related Metrics
PE Ratio | 77.06 |
PS Ratio | 2.695 |
Price to Book Value | 1.760 |
Price to Free Cash Flow | 32.89 |
Earnings Yield | 1.30% |
Market Cap | 156.64B |
Operating PE Ratio | 46.93 |
Normalized PE Ratio | 26.06 |